Filtros de búsqueda

Lista de obras de

(I) Re: prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml

scientific article published on 01 April 2008

4-year prostate specific antigen progression and diagnosis of prostate cancer in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.

artículo científico publicado en 2005

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

artículo científico publicado en 2019

A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam

artículo científico publicado en 2012

A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment

artículo científico publicado en 2016

A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

artículo científico publicado en 2016

A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings

article

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy

artículo científico publicado en 2019

A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of a symptomatic men aged 55-75 years using a biopsy indication of 3.0 ng/ml (results of ERSPC, Rotterdam).

artículo científico publicado en 2006

A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial

artículo científico publicado en 2010

A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality.

artículo científico publicado en 2014

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.

artículo científico publicado en 2010

A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

artículo científico publicado en 2010

A framework for the identification of men at increased risk for prostate cancer.

artículo científico publicado en 2009

A graphical device to represent the outcomes of a logistic regression analysis.

artículo científico publicado en 2008

A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels

artículo científico publicado en 2014

A more advanced clinical stage is positively correlated with an increased prostate cancer detection rate.

artículo científico publicado en 2002

A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients.

artículo científico publicado en 2013

A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy

artículo científico publicado en 2017

A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.

artículo científico publicado en 2009

Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening.

artículo científico publicado en 2015

Active Surveillance for Low-risk Prostate Cancer: Will it Become Obsolete?

artículo científico publicado en 2018

Active surveillance for low-risk prostate cancer

artículo científico publicado en 2013

Active surveillance for low-risk prostate cancer - in pursuit of a standardized protocol

artículo científico publicado en 2020

Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.

artículo científico publicado en 2012

Active surveillance for prostate cancer: a legal perspective

artículo científico publicado en 2014

Active surveillance for prostate cancer: a narrative review of clinical guidelines

artículo científico publicado en 2016

Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification.

artículo científico publicado en 2014

Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome

scientific article published on 05 December 2006

Active surveillance: a review of risk-based, dynamic monitoring.

artículo científico publicado en 2018

Active surveillance: oncologic outcome

artículo científico

Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population

scientific article published on 29 November 2016

Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer

artículo científico publicado en 2017

Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative

scientific article published on 26 September 2019

Algorithms, nomograms and the detection of indolent prostate cancer

artículo científico publicado en 2008

An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

artículo científico publicado en 2020

Analytical issues on prostate-specific antigen in relation to prostate cancer screening

artículo científico publicado en 1998

Anxiety and distress during active surveillance for early prostate cancer.

artículo científico publicado en 2009

Assessing a Patient's Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood

scientific article published on 17 August 2019

Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios

artículo científico publicado en 2020

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

artículo científico publicado en 2018

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry

scientific article published in Nature Communications

Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research

artículo científico publicado en 2020

Balancing the harms and benefits of early detection of prostate cancer.

artículo científico publicado en 2010

Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement

scientific article published on 07 March 2019

Biochemical progression rates in the screen arm compared to the control arm of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer (ERSPC)

artículo científico publicado en 2006

Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam

artículo científico publicado en 2017

Blinded and uniform causes of death verification in cancer screening: A major influence on the outcome of a prostate cancer screening trial? ⬇️

artículo científico publicado el 1 de noviembre de 2010

Can PSA density be used to detect prostate cancer?

Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study

artículo científico publicado en 2018

Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after 4 years?

artículo científico publicado en 2007

Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?

artículo científico publicado en 2013

Cancer Detection and Cancer Characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) – Section Rotterdam

artículo científico publicado en 2007

Challenges of urine-based molecular assays for the detection of urothelial cancer

scientific article published on 01 December 2019

Change of tumour characteristics and treatment over time in both arms of the European Randomized study of Screening for Prostate Cancer ⬇️

artículo científico publicado el 1 de noviembre de 2010

Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7.

artículo científico publicado en 2017

Characteristics of Prostate Cancer Found at Fifth Screening in the European Randomized Study of Screening for Prostate Cancer Rotterdam: Can We Selectively Detect High-grade Prostate Cancer with Upfront Multivariable Risk Stratification and Magnetic

artículo científico publicado en 2017

Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study

artículo científico publicado en 2018

Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening

scientific article published on 01 September 2004

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy

scientific article published on 16 January 2020

Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI

artículo científico publicado en 2020

Clinicopathological characteristics of glomeruloid architecture in prostate cancer

artículo científico publicado en 2020

Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.

artículo científico publicado en 2014

Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and

scientific article published on 11 April 2020

Comparison of Tumor Volume Parameters on Prostate Cancer Biopsies

artículo científico publicado en 2020

Comparison of Two Prostate Cancer Risk Calculators that Include the Prostate Health Index.

artículo científico publicado en 2015

Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies

artículo científico publicado en 2020

Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients

artículo científico publicado en 2020

Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy

article

Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort

article

Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.

artículo científico publicado en 2005

Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers.

artículo científico publicado en 2015

Compliance with biopsy recommendations of a prostate cancer risk calculator.

artículo científico publicado en 2011

Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program

artículo científico publicado en 2002

Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study.

artículo científico publicado en 2016

Complications of initial prostate biopsy in a European randomized screening trial

artículo científico publicado en 2013

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens

scientific article published on 02 August 2019

Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies

scientific article published on 13 September 2018

Contemporary role of prostate cancer gene 3 in the management of prostate cancer ⬇️

artículo científico publicado el 1 de mayo de 2011

Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care

artículo científico

Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).

artículo científico publicado en 2016

Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data

artículo científico publicado en 2014

Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?

scientific article published on 28 March 2019

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients

artículo científico publicado en 2020

Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortality

artículo científico publicado el 1 de diciembre de 2011

Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome

scientific article published on 16 March 2011

De klinische relevantie van cribriforme en intraductale prostaatkanker in diagnostische naaldbiopten

Defining and predicting indolent and low risk prostate cancer

artículo científico

Defining increased future risk for prostate cancer: evidence from a population based screening cohort.

artículo científico publicado en 2008

Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer

artículo científico publicado en 2009

Defining the threshold for significant versus insignificant prostate cancer.

artículo científico publicado en 2013

Design-corrected variation by centre in mortality reduction in the ERSPC randomised prostate cancer screening trial.

artículo científico publicado en 2016

Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer Rotterdam

artículo científico publicado en 2022

Detection characteristics in randomized prostate screening

artículo científico publicado en 2004

Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer ⬇️

artículo científico publicado el 1 de noviembre de 2010

Detection rates of high-grade prostate cancer during subsequent screening visits. Results of the European Randomized Screening Study for Prostate Cancer

artículo científico publicado en 2006

Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69Yr: The PSAInForm Trial

artículo científico publicado en 2019

Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam

scientific article published on 18 October 2014

Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer

scientific article published on 24 April 2019

Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.

artículo científico publicado en 2008

Digital rectal examination can detect early prostate cancer.

artículo científico publicado en 2015

Disease insight and treatment perception of men on active surveillance for early prostate cancer.

artículo científico publicado en 2009

Disease-specific mortality may underestimate the total effect of prostate cancer screening

artículo científico publicado en 2010

Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.

artículo científico publicado en 2011

Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy

artículo científico publicado en 2016

Distribution of Prostate Imaging Reporting and Data System score and diagnostic accuracy of magnetic resonance imaging-targeted biopsy: comparison of an Asian and European cohort

scientific article published on 22 October 2018

Do Treatment Differences between Arms Affect the Main Outcome of ERSPC Rotterdam?

artículo científico publicado en 2015

Do anxiety and distress increase during active surveillance for low risk prostate cancer?

artículo científico publicado en 2010

Does "normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey.

artículo científico publicado en 2008

Does PSA velocity predict prostate cancer in pre-screened populations?

artículo científico publicado en 2006

EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

artículo científico publicado en 2019

ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer

artículo científico publicado en 2011

ERSPC and PLCO prostate cancer screening studies: what are the differences?

artículo científico publicado en 2010

Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission

artículo científico publicado en 2020

Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics.

artículo científico publicado en 2007

Editorial Comment to Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial

scientific article published on 01 March 2018

Editorial comment

artículo científico publicado en 2010

Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillance.

artículo científico publicado en 2017

Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam)

article

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality.

artículo científico publicado en 2012

Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies.

artículo científico publicado en 2009

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

artículo científico publicado en 2014

Epilogue: different approaches for prostate cancer screening in the EU?

artículo científico publicado en 2010

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies

artículo científico publicado en 2020

Erectile dysfunction and mental health in a general population of older men.

artículo científico publicado en 2008

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.

artículo científico publicado en 2016

Ethnicity and prostate cancer: the way to solve the screening problem?

artículo científico publicado en 2015

Europa Uomo Patient Reported Outcome Study (EUPROMS): Descriptive Statistics of a Prostate Cancer Survey from Patients for Patients

artículo científico publicado en 2020

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

artículo científico publicado en 2011

Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

artículo científico publicado en 2012

Excess all-cause mortality in the evaluation of a screening trial to account for selective participation.

artículo científico publicado en 2013

Expert Involvement Predicts mHealth App Downloads: Multivariate Regression Analysis of Urology Apps

artículo científico publicado en 2016

Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure

artículo científico

External validation of novel magnetic resonance imaging-based models for prostate cancer prediction

scientific article published on 20 December 2019

False-negative Prostate Needle Biopsies: Frequency, Histopathologic Features, and Follow-up

artículo científico publicado en 2010

False-positive screening results in the European randomized study of screening for prostate cancer

artículo científico publicado en 2011

Feasibility study of adjustment for contamination and non-compliance in a prostate cancer screening trial

scientific article published on 01 July 2007

Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).

artículo científico publicado en 2010

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

artículo científico publicado en 2018

From PROMIS to PRO-MRI in primary prostate cancer diagnosis.

artículo científico publicado en 2017

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

artículo científico publicado en 2018

Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 men

scientific article published on 19 January 2009

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.

artículo científico publicado en 2018

Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN

artículo científico publicado en 2020

How Often is Biopsy Necessary in Patients with Prostate Cancer on Active Surveillance?

artículo científico publicado en 2015

How common is PSA screening in elderly men with limited life expectancies?

artículo científico publicado en 2007

IMAGINE-IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines

artículo científico publicado en 2020

Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam).

artículo científico publicado en 2011

Impact of Early Diagnosis of Prostate Cancer on Survival Outcomes.

artículo científico publicado en 2015

Impact of cause of death adjudication on the results of the European prostate cancer screening trial.

artículo científico publicado en 2016

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial

artículo científico publicado en 2013

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial

artículo científico publicado en 2013

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.

artículo científico publicado en 2011

Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups

artículo científico publicado en 2019

Improving prediction models with new markers: a comparison of updating strategies

artículo científico publicado en 2016

Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth

artículo científico publicado en 2017

Improving the evaluation and diagnosis of clinically significant prostate cancer in 2017.

artículo científico publicado en 2017

Incidence and follow-up of patients with focal prostate carcinoma in 2 screening rounds after an interval of 4 years

scientific article published on 01 February 2005

Increased non-prostate cancer death risk in clinically diagnosed prostate cancer

artículo científico publicado en 2012

Infectious complications and hospital admissions after prostate biopsy in a European randomized trial

artículo científico publicado en 2012

Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator

artículo científico publicado en 2010

Informed decision-making based on a leaflet in the context of prostate cancer screening

artículo científico publicado en 2019

International perspectives on screening.

artículo científico publicado en 2014

Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam

artículo científico publicado en 2007

Interval cancers in the Antwerp European randomised study of screening for prostate cancer study, using a 6 year screening interval

scientific article published on 01 November 2010

Intraductal carcinoma has minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens

artículo científico publicado en 2020

Intraoperative assessment and reporting of radical prostatectomy specimens to guide nerve-sparing surgery in prostate cancer patients (NeuroSAFE)

scientific article published on 18 June 2020

Introducing PIONEER: a project to harness big data in prostate cancer research

artículo científico publicado en 2020

Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting? (ERSPC, section Rotterdam).

artículo científico publicado en 2005

Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes?

artículo científico publicado en 2010

Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC.

artículo científico publicado en 2008

Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis

article

Is prostate cancer screening bad or good? Summary of a debate at the innovation in urology meeting, September 17-19, 2010, Milan, Italy

artículo científico publicado el 26 de octubre de 2010

Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).

artículo científico publicado en 2008

Is prostatectomy for Gleason score 6 a treatment failure?

artículo científico publicado en 2014

Is transrectal ultrasonography of the prostate obsolete in the MRI era?

scientific article published on 01 March 2019

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis

article

Lesions predictive for prostate cancer in a screened population: First and second screening round findings

scientific article published on 01 November 2004

Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer.

artículo científico publicado en 2017

Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.

artículo científico publicado en 2012

MRI pathway and TRUS‐guided biopsy for detecting clinically significant prostate cancer

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

artículo científico publicado en 2018

Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.

artículo científico publicado en 2014

Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.

artículo científico publicado en 2006

Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - the two highest quality studies identified do find prostate cancer-related mortality

scientific article published on 12 January 2011

Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer

artículo científico publicado en 2015

Multiparametric Ultrasound for Prostate Cancer Detection and Localization: Correlation of B-mode, Shear Wave Elastography and Contrast Enhanced Ultrasound with Radical Prostatectomy Specimens

scientific article published on 27 June 2019

Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic.

artículo científico publicado en 2018

Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions

artículo científico publicado en 2019

No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer

scientific article published on 15 October 2010

Nomogram use for the prediction of indolent prostate cancer

scientific article published on 01 November 2007

Nonlinear modeling was applied thoughtfully for risk prediction: the Prostate Biopsy Collaborative Group

artículo científico publicado en 2014

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer

artículo científico publicado en 2010

Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.

artículo científico publicado en 2013

Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer

artículo científico publicado en 2012

Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly

scientific article published on 17 September 2008

Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method

artículo científico publicado en 2013

PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer ⬇️

artículo científico publicado el 1 de noviembre de 2010

PSA-based prostate cancer screening: the role of active surveillance and informed and shared decision making.

artículo científico publicado en 2011

PSMA PET/CT in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer

artículo científico publicado en 2020

Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment

artículo científico publicado en 2013

Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in Prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥ 100).

artículo científico publicado en 2010

Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test

artículo científico publicado en 2010

Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs

scientific article published on 18 July 2019

Personalized schedules for surveillance of low-risk prostate cancer patients

scientific article published on 23 July 2018

Personalized strategies in population screening for prostate cancer

scientific article published on 11 May 2020

Perspective: Enforce the clinical guidelines.

artículo científico publicado en 2015

Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*.

artículo científico publicado en 2012

Potentially advanced malignancies detected by screening for prostate carcinoma after an interval of 4 years

artículo científico publicado en 2004

Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts

scientific article published on 24 August 2019

Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies

artículo científico publicado en 2016

Predicting biochemical recurrence and prostate cancer-specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening- and clinically detected prostate cancer

scientific article published on 04 May 2019

Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis ⬇️

artículo científico publicado en 2019

Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators

scientific article published on 03 August 2018

Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

artículo científico publicado en 2007

Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort.

artículo científico publicado en 2016

Prediction of prostate cancer in unscreened men: external validation of a risk calculator

artículo científico publicado en 2010

Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators

artículo científico publicado en 2011

Predictive models in diagnosing indolent cancer.

artículo científico publicado en 2009

Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS).

artículo científico publicado en 2015

Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam.

artículo científico publicado en 2013

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program

artículo científico publicado en 2011

Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.

artículo científico publicado en 2017

Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?

artículo científico publicado en 2005

Prevalence, Treatment Modalities and Prognosis of Familial Prostate Cancer in a Screened Population

scientific article published on 01 April 2006

Profiling of antibody production against xenograft-released proteins by protein microarrays discovers prostate cancer markers

artículo científico publicado en 2011

Propensity score matching, competing risk analysis, and a competing risk nomogram: some guidance for urologists may be in place

artículo científico publicado en 2011

Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above

artículo científico publicado en 2016

Prospective evaluation on the effect of interobserver variability of digital rectal examination on the performance of the Rotterdam Prostate Cancer Risk Calculator.

artículo científico publicado en 2017

Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort.

artículo científico publicado en 2012

Prospective validation of active surveillance in prostate cancer: the PRIAS study

scientific article published on 25 May 2007

Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely? ⬇️

artículo científico publicado el 16 de abril de 2011

Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy

scientific article published on 15 May 2018

Prostate Carcinoma Grade and Length But Not Cribriform Architecture at Positive Surgical Margins Are Predictive for Biochemical Recurrence After Radical Prostatectomy

artículo científico publicado en 2020

Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer

scientific article published on 25 April 2019

Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis

scientific article published on 18 July 2019

Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects.

artículo científico

Prostate cancer antigen 3: diagnostic outcomes in men presenting with urinary prostate cancer antigen 3 scores ≥100

artículo científico publicado en 2014

Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml: value of percent free prostate specific antigen on tumor detection and tumor aggressiveness

artículo científico publicado en 2004

Prostate cancer diagnosis: the impact on patients' mental health.

artículo científico publicado en 2005

Prostate cancer epidemic in sight?

artículo científico publicado en 2012

Prostate cancer from the horizon of the patient.

artículo científico publicado en 2011

Prostate cancer in the Swedish section of ERSPC--evidence for less metastases at diagnosis but not for mortality reduction

artículo científico publicado en 2006

Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam

artículo científico publicado en 2011

Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.

artículo científico publicado en 2009

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

artículo científico publicado en 2009

Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma

artículo científico publicado en 2016

Prostate cancer screening and active surveillance in the Western world.

artículo científico publicado en 2018

Prostate cancer screening in Europe and Asia.

artículo científico publicado en 2016

Prostate cancer screening in Europe – Authors' reply

artículo científico publicado en 2015

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

artículo científico publicado en 2012

Prostate cancer upgrading with serial prostate MRI scans and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?

scientific article published on 31 March 2020

Prostate cancer: Draft USPSTF 2017 recommendation on PSA testing - a sea-change?

artículo científico publicado en 2017

Prostate cancer: Rescreening policies and risk calculators

artículo científico publicado en 2014

Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.

artículo científico publicado en 2005

Prostate health index (PHI) and prostate-specific antigen (PSA) predictive models for prostate cancer in the Chinese population and the role of digital rectal examination-estimated prostate volume.

artículo científico publicado en 2016

Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy

artículo científico publicado en 2010

Prostate-cancer mortality at 11 years of follow-up

artículo científico publicado en 2012

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.

artículo científico publicado en 2010

Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam

artículo científico publicado en 2004

Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.

artículo científico publicado en 2008

Prostate-specific antigen screening can be beneficial to younger and at-risk men.

artículo científico publicado en 2012

Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.

artículo científico publicado en 2010

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort

artículo científico publicado en 2009

Prostate-specific antigen-based prostate cancer screening: Past and future

artículo científico

Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer

artículo científico publicado en 2013

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

scientific article published on 23 September 2019

Quality-of-life effects of prostate-specific antigen screening.

artículo científico publicado en 2012

RE: Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection

artículo científico publicado en 2014

Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results From a Prospective Observational Study

scientific article published on 14 February 2012

Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement

artículo científico publicado en 2005

Re: Is a screening interval of every 4 years for prostate cancer acceptable?

artículo científico publicado en 2008

Re: Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk

artículo científico publicado en 2007

Re: Prospective Evaluation of Operating Characteristics of Prostate Cancer Detection Biomarkers ⬇️

artículo científico publicado el 1 de julio de 2011

Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial

scientific article published on 05 December 2008

Re: Re-evaluating PSA Testing Rates in the PLCO Trial.

artículo científico publicado en 2016

Real-time Watchful Surveillance Looks Like Active Waiting.

artículo científico publicado en 2017

Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

article by Mieke Van Hemelrijck et al published 29 October 2018 in European Urology

Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

article by Mieke Van Hemelrijck et al published March 2019 in European Urology

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

artículo científico publicado en 2017

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data

artículo científico publicado en 2022

Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore

scientific article published on 07 December 2018

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication

artículo científico publicado en 2010

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease.

artículo científico publicado en 2018

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

Reply by Authors

Reply by authors: Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore

artículo científico publicado en 2019

Reply from Authors re: Noel W. Clarke. Coming Up for Air: Follow-up and Risk Stratification After Negative Prostate Cancer Screening. Eur Urol 2013;63:634–5

Reply from authors re: Brant A. Inman, Michael R. Abern. Interpreting a study on bladder cancer screening. Eur Urol 2013;64:48-50: the goal of cancer screening: early evaluation of screening for bladder cancer.

artículo científico publicado en 2013

Reply from authors re: Michael Baum. Screening for prostate cancer: can we learn from the mistakes of the breast screening experience? Eur Urol 2013;64:540-1: screening for prostate cancer: we have learned and are still learning.

artículo científico publicado en 2013

Reply to Gianluca Giannarini, Nazareno Suardi and Alberto Briganti's letter to the editor re: Prasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F. Shariat, et al. A multinational, multi-institutional study comparing positive surgical margin rate

artículo científico publicado en 2014

Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators

artículo científico publicado en 2018

Restricting False-positive Magnetic Resonance Imaging Scans to Reduce Overdiagnosis of Prostate Cancer

artículo científico publicado en 2020

Results of Prostate Cancer Screening in a Unique Cohort at 19yr of Follow-up

artículo científico publicado en 2018

Risk stratification in prostate cancer screening.

artículo científico publicado en 2012

Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.

artículo científico publicado en 2015

Risk-based prostate cancer screening.

artículo científico publicado en 2011

Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer

artículo científico publicado en 2017

Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App.

artículo científico publicado en 2017

Rotterdam Randomized Pilot Studies of Screening for Prostate Cancer—An Overview After 10 Years

artículo científico publicado en 2005

Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer

artículo científico publicado en 2015

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

artículo científico publicado en 2014

Screening and prostate-cancer mortality in a randomized European study

artículo científico publicado en 2009

Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristics

artículo científico publicado en 2007

Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).

artículo científico publicado en 2012

Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.

artículo científico publicado en 2008

Screening for prostate cancer without digital rectal examination and transrectal ultrasound: results after four years in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.

artículo científico publicado en 2006

Screening for prostate cancer: are organized screening programs necessary?

artículo científico publicado en 2018

Screening for prostate cancer: early detection or overdetection?

artículo científico publicado en 2011

Screening for prostate cancer: have we resolved the controversy?

artículo científico publicado en 2010

Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.

artículo científico publicado en 2013

Screening: should more biopsies be taken in larger prostates?

artículo científico publicado en 2009

Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study

scientific article published on 23 November 2011

Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.

artículo científico publicado en 2012

Selective detection of aggressive prostate cancer

scientific article published on 15 July 2011

Serendipity in detecting disease in low prostate-specific antigen ranges.

artículo científico publicado en 2002

Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force

artículo científico publicado en 2016

Sexual function with localized prostate cancer: active surveillance vs radical therapy.

artículo científico publicado en 2012

Shared heritability and functional enrichment across six solid cancers

artículo científico publicado en 2019

Shared heritability and functional enrichment across six solid cancers

Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study.

artículo científico publicado en 2009

Should Pathologists Routinely Report Prostate Tumour Volume? The Prognostic Value of Tumour Volume in Prostate Cancer

artículo científico publicado en 2009

Should prostate-specific antigen screening be offered to asymptomatic men?

artículo científico publicado en 2010

Single Prostatic Cancer Foci on Prostate Biopsy

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019

scientific article published on 12 May 2019

Summary statement on screening for prostate cancer in Europe

artículo científico publicado en 2017

Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands

artículo científico publicado en 2009

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

artículo científico publicado en 2020

The ERSPC Study: Quality Takes Time and Perseverance

artículo científico publicado en 2018

The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers

scientific article published on 26 April 2019

The Melbourne Consensus Statement on the early detection of prostate cancer

artículo científico

The Movember Foundation's GAP3 cohort: A profile of the largest global prostate cancer active surveillance database to date

artículo científico publicado en 2017

The Optimal Timing for PSMA PET/CT in Patients with Biochemical Recurrence After Radical Prostatectomy

artículo científico publicado en 2020

The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison.

artículo científico publicado en 2008

The Prostate cancer Research International: Active Surveillance study

artículo científico publicado en 2012

The ProtecT trial: what can we expect?

artículo científico publicado en 2014

The REDUCE Trial

artículo científico publicado en 2010

The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.

artículo científico publicado en 2014

The distribution of prostate cancer recurrences on 68 Ga-PSMA PET/CT after radical prostatectomy with pathological node positive extended lymph node dissection

artículo científico publicado en 2020

The effect of study arm on prostate cancer treatment in the large screening trial ERSPC.

artículo científico publicado en 2010

The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.

artículo científico publicado en 2016

The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.

artículo científico publicado en 2017

The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer.

artículo científico publicado en 2008

The need for active surveillance for low risk prostate cancer

artículo científico publicado en 2017

The prostate-specific antigen test.

artículo científico publicado en 2013

The rate of overdiagnosis inextricably linked to prostate-specific antigen-based screening for prostate cancer can be quantified in several ways, but what is the practicable message?

artículo científico publicado en 2014

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group

artículo científico publicado en 2010

The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam

artículo científico publicado en 2008

The use of nomograms in the detection of prostate cancer.

artículo científico publicado en 2006

The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancer

scientific article published on 01 March 2008

Towards an optimal interval for prostate cancer screening.

artículo científico publicado en 2011

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

artículo científico publicado en 2021

Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors ⬇️

artículo científico publicado el 14 de mayo de 2013

Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam

artículo científico publicado en 2006

Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml)

artículo científico publicado en 2001

Tumour Features in the Control and Screening Arm of A Randomized Trial of Prostate Cancer

artículo científico publicado en 2005

Tumour markers in prostate cancer III: biomarkers in urine.

artículo científico publicado en 2011

Unorganized prostate-specific antigen-based screening for prostate cancer: more harm than benefit. When will we finally start to implement guidelines and risk assessment tools in clinical practice?

artículo científico publicado en 2015

Updating the prostate cancer risk indicator for contemporary biopsy schemes

artículo científico publicado el 1 de abril de 2011

Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literat

scientific article published on 29 November 2019

Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.

artículo científico publicado en 2013

Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study

artículo científico publicado en 2014

What explains the differences between centres in the European screening trial? A simulation study.

artículo científico publicado en 2016

What is an acceptable false negative rate in the detection of prostate cancer?

artículo científico publicado en 2018

What's new in screening in 2015?

artículo científico publicado en 2016

Where we are with screening and risk prediction for prostate cancer in 2016

artículo científico publicado en 2016

Words of wisdom. Re: Estimating the benefits of PSA screening

scientific article published on 01 January 2010

Words of wisdom. Re: Mortality results from a randomized prostate- cancer screening Trial

artículo científico publicado en 2009

Words of wisdom. Re: PSA density improves prediction of prostate cancer

artículo científico publicado en 2014

Words of wisdom. Re: prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years

artículo científico publicado en 2007

[Early detection of prostate cancer--recommendations after 13 years of follow-up in the European randomised study]

artículo científico publicado en 2015

[Guidelines on the early detection of prostate cancer]

mHealth in Urology: A Review of Experts' Involvement in App Development

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda